If you’ve ever asked whether a medication is safe to take during pregnancy and been met with a careful shrug, you’re not alone.
For decades, pregnant women have been navigating treatment decisions with little more than guesswork, vague warnings, and the phrase “there just isn’t enough research.” Most medicines simply haven’t been tested in pregnancy, not because no one needs the answers, but because pregnant bodies have long been excluded from medical research. Now, the World Health Organization says that may finally be about to change.
Jump to…
Why so many pregnant women hear “we don’t know”
“Hm, we don’t really know why you feel like that, it’s probably just pregnancy symptoms.”
For many women, this phrase becomes painfully familiar during pregnancy, especially when medication is involved. Whether it’s treatment for nausea, pain, mental health conditions, epilepsy, diabetes or heart disease, pregnant women are often told there simply isn’t enough evidence to say whether a medicine is safe.
This uncertainty isn’t because doctors aren’t trying to help. It’s because, for decades, pregnant women have been excluded from clinical drug trials. As a result, more than 90 per cent of medicines have never been formally tested in pregnancy, leaving women to make deeply personal decisions without clear guidance.
The choice is rarely simple: stop a medicine that keeps you well, or continue taking it while carrying the emotional burden of “what if”. For many, that uncertainty brings guilt, anxiety and fear, emotions no one should have to carry alone during pregnancy.
The thalidomide legacy and the cost of fear
The roots of this problem trace back to one of the biggest medical tragedies of the 20th century. In the late 1950s and early 1960s, thalidomide was prescribed to pregnant women to treat morning sickness. At the time, it wasn’t understood that medicines could cross the placenta.
The result was devastating: thousands of babies were born with severe limb and organ abnormalities.
In response, drug safety laws were tightened across the UK and globally, a vital and necessary step. But pregnant women, whose experiences had exposed the dangers of poor testing, were subsequently excluded altogether from clinical trials.
This exclusion wasn’t driven by disregard, but fear. Researchers worried about causing harm. Regulators worried about liability. Over time, the default position became: it’s safer not to include pregnant women at all.
But decades later, experts now recognise that this caution has created a different kind of risk, one where pregnant women are treated without evidence, rather than protected by it.
Why exclusion creates real health risks
Pregnancy doesn’t make women immune to illness. In fact, it can make some conditions worse.
Globally, after severe bleeding, chronic illnesses such as heart disease, diabetes and epilepsy are among the leading causes of maternal deaths. In the UK, many pregnant women rely on long-term medications to stay healthy, yet often those medicines come with labels that say “not tested in pregnancy” or “use only if benefits outweigh risks”.
Without pregnancy-specific data, clinicians are forced to extrapolate from studies in men or non-pregnant adults, despite pregnancy causing major physiological changes, including increased blood volume, altered metabolism and different drug absorption.
This means responsibility quietly shifts onto women themselves. Doctors are left saying “we don’t know”, while pregnant women are asked to make decisions with incomplete information, often while feeling unwell, vulnerable or overwhelmed.
A long-overdue shift: what the WHO Is planning
Now, something significant may finally be changing.
The World Health Organization (WHO) has announced plans to support the ethical and safe inclusion of pregnant women in clinical drug trials, describing the move as a generational shift in medical research.
Rather than excluding pregnant women by default, the WHO wants pregnancy to be considered from the very start of drug development, especially for medicines likely to be used by women of reproductive age.
Crucially, this does not mean testing drugs recklessly. Modern trials follow strict, step-by-step processes: laboratory testing, animal studies, trials in non-pregnant adults, and only then carefully monitored inclusion of pregnant women where appropriate.
Experts argue that clinical trials are actually safer environments than real-world prescribing, because participants are closely monitored and adverse effects are picked up early.
Why this matters for UK women
In the UK, guidance on medicines in pregnancy often relies on limited data, observational studies or post-marketing reports, not controlled trials designed for pregnant bodies.
This has real consequences. Women report being taken off medication without alternatives, told symptoms are “just pregnancy”, or left weighing up risks alone. For women with disabilities, chronic illness or mental health conditions, the stakes are even higher.
UK regulators, including the Medicines and Healthcare products Regulatory Agency (MHRA), have acknowledged the need for change and are engaging with international efforts to update guidelines. The aim is not to pressure women into trials, but to restore choice.
From paternalism to informed consent
Health advocates argue that excluding pregnant women from research isn’t just a scientific issue, it’s an ethical one.
Pregnant women are capable of understanding risk. They deserve the same right to informed consent as anyone else. Instead of being protected from research, many argue women should be protected through research.
A similar shift has already happened in paediatric medicine. Until around 20 years ago, children were routinely excluded from trials and treated as “small adults” when prescribed medication. Today, medicines are commonly tested specifically in children where safe, improving outcomes and reducing guesswork.
Campaigners believe pregnancy should follow the same path.
Why this conversation matters now
This isn’t about encouraging medication use in pregnancy. It’s about honesty, transparency and evidence.
If the WHO’s plans succeed, future generations of women may finally receive clear, evidence-based guidance, rather than silence, when they ask the simplest question of all: Is this safe for me and my baby?
Want more like this, delivered direct to your inbox? Sign up for our free digital magazine…
Feature image: Supplied
Birthbabe is supported by the beautiful babes who enjoy our content. We only recommend products used and approved by mamas, however we may receive an affiliate commission.
Birthbabe does not provide medical advice, diagnosis, or treatment. The resources on our website are provided for informational purposes only. You should always consult with a healthcare professional regarding any medical diagnoses or treatment options.